MarketNeurotherapeutics
Company Profile

Neurotherapeutics

Neurotherapeutics is a quarterly peer-reviewed medical journal covering research on experimental treatments of neurological disorders. It was established in 2004 and is published by Elsevier Inc. on behalf of the American Society for Experimental NeuroTherapeutics. The editor-in-chief is Maral Mouradian. The founding editor-in-chief was Alan I. Faden.

Abstracting and indexing
The journal is abstracted and indexed in: According to the Journal Citation Reports, the journal has a 2020 impact factor of 7.620. == References ==
tickerdossier.comtickerdossier.substack.com